Increase in Capacity to Meet Heightened Demand for Medical Product Manufacturing Services for Pharmaceutical and Medical Device Companies
ONTARIO, Calif.--(BUSINESS WIRE)--Medegen Inc., a leading provider of medical devices, components and manufacturing services to the healthcare industry, today announced it has expanded its manufacturing capabilities into Tijuana, Mexico. The recently opened facility will enable Medegen, through its Manufacturing Services operating unit, to meet the heightened demand for outsourced contract manufacturing as the medical device market is forecasted to grow at an annual rate of 10%.
Contract manufacturing, whereby medical device companies outsource the manufacturing of their products to partners like Medegen, is expected to reach the $8 billion mark industry-wide by year end.
“Expansion of our manufacturing facilities will provide medical device companies with high-quality and cost-effective outsourcing solutions,” said Jeff Goble, President of Medegen. “This marks a new milestone for Medegen as we focus on growing our medical manufacturing services business unit, while continuing to develop innovative Maximus brand technologies for the intravenous medication delivery market.”
The new 42,000-square-foot facility will enhance contract manufacturing capabilities to the medical device and pharmaceutical industries significantly expanding the services of Medegen’s Manufacturing Services operating unit.
The facility will also handle Medegen’s finished goods assembly for its Maximus brand of IV therapy products that feature Tru-Swab™ valve technology.
“Coupling Ontario-based medical device development resources with the device assembly capabilities of the Tijuana operation allows Medegen to offer a comprehensive range of manufacturing services,” said Ross Magladry, Medegen’s Vice President of Business Development, Manufacturing Services. “This expansion provides the market a one-stop alternative encompassing a scope of services from product design through sterile device distribution.”
The brand new, FDA-registered manufacturing plant features state-of-the-art clean rooms and is FDA QSR compliant and ISO 13485 certified. The facility is conveniently located within a mile of the Otay Mesa crossing in the Parque Industrial Chilpancingo in Tijuana, Mexico.
For a view of available hi-res photos, visit: http://www.flickr.com/photos/medegen.
About Medegen Inc.
Medegen is a leading innovator in infusion therapy, focused on helping hospitals drive greater clinical performance for improved patient care. The growing company provides clinically superior medical products and reliable, cost-effective manufacturing services to the medical community through its three operating units: Manufacturing Services, Maximus and KippMed. Manufacturing Services provides cost-effective contract manufacturing solutions to medical device and pharmaceutical companies. KippMed manufactures and markets IV therapy components for the OEM market, drawing from a 25-year history in IV component supply. Maximus develops, manufactures and markets needleless intravenous therapy products for the acute care market. The Maximus line of medical products feature patent-protected technologies which improve patient outcomes and greatly reduce bloodstream infection rates. Medegen is headquartered in Ontario, Calif., with executive offices in Scottsdale, Ariz. and operations in Tijuana, Mexico. For more, visit http://www.medegen.com/.
Kathy Sacks, 602-619-4444
Source: Medegen Inc.